Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 3 (2006), Issue 4 (April)

1. A prospective study of night shift work, sleep duration, and risk of Parkinson's disease.
   Am J Epidemiol, 163(8): 726-30. [Abstract] [Full-text]
2. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
   J Neurosci, 26(14): 3685-96. [Abstract] [Full-text]
3. Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease.
   Neurology, 66(7): 1097-9. [Abstract] [Full-text]
4. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
   Neurology, 66(7): 996-1002. [Abstract] [Full-text]
5. Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
   Neurology, 66(7): 983-95. [Abstract] [Full-text]
6. Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
   Neurology, 66(7): 976-82. [Abstract] [Full-text]
7. Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
   Neurology, 66(7): 968-75. [Abstract] [Full-text]
8. Volunteering for early phase gene transfer research in Parkinson disease.
   Neurology, 66(7): 1010-5. [Abstract] [Full-text]
9. Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort.
   J Neurol Neurosurg Psychiatry, 77(5): 665-7. [Abstract] [Full-text]
10. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry, 77(5): 585-9. [Abstract] [Full-text]
11. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 77(5): 579-84. [Abstract] [Full-text]
12. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease.
    Brain, 129: 1188-93. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.